Microfluidic chip device for combined detection of typical tumor markers of male

Abstract

The invention relates to a microfluidic chip device for combined detection of typical tumor markers of a male, and belongs to the field of analysis and testing. Polydimethylsiloxane, i.e. PDMS, is used as a substrate for preparing the microfluidic chip for combined detection of seven typical tumor markers of a male, which has a plurality of advantages but also has a series of challenges. Aiming at the series of challenges, the invention is provided. The key points of the invention are as follows: the PDMS with an original form surface is selected as the substrate; an elastic clamp is elastically clamped and located in a position adjacent to a sample liquid flow terminal of the microfluidic chip, wherein a micro ultrasonic transducer is attached to clamping arms of the elastic clamp; and meanwhile, the sample injection end of the microfluidic chip is provided with an ultrasonic attenuator, so that the ultrasonic strength quickly descends within a short distance, and an interfacial tension difference is formed between both ends of the chip, thereby urging a sample liquid flow to flow towards the terminal along an original hydrophobic capillary channel. Besides, the device avoids the use of a micropump.

Description

technical field [0001] The invention relates to a microfluidic chip device for combined detection of typical male tumor markers, belonging to the field of analysis and testing. Background technique [0002] Tumor markers (tumor markers, TM) refer to a class of substances produced by tumor cells themselves or produced by the body's response to tumor cells during the occurrence and proliferation of tumors, reflecting the existence and growth of tumors, including Proteins, hormones, enzymes (isoenzymes) and oncogene products, etc. Testing the tumor markers in the patient's blood or body fluids can detect tumors early in the tumor screening, observe the curative effect of tumor treatment and judge the prognosis of patients. Currently, the tumor markers commonly used clinically are: (1) alpha-fetoprotein (AFP) is a marker for primary liver cancer, testicular cancer, ovarian cancer and other tumors; (2) carcinoembryonic antigen (CEA) is a marker for digestive system tumors, (3) ...

AI Technical Summary

Problems solved by technology

[0008] But it's not that simple

[0009] First, this polydimethylsiloxane material, the material referred to by the acronym PDMS, is itself a strongly hydrophobic material. Microchannels are built on this material. If the microchannels are not targeted The modification operation of the surface of the channel, then, after the overall assembly is completed, that is, after the cover is covered, because the inner surface of the micro channel in the structure occupies most of the inner surface of the liquid flow channel, then the PDMS micro channel The strong hydrophobic characteristic of the inner surface of the channel is the decisive factor, which will make it very difficult for the polar liquid flow similar to the aqueous solution to pass through, and its flow resistance is so large that even ordinary micropumps are difficult to push. Of course, If the cover sheet also chooses to use the PDMS material, then the problem is basically the same, with little difference; therefore, in the prior art, it is necessary to modify and modify the inner surface of the microchannel on the PDMS material; then , is this modification operation for the inner surface of the PDMS microchannel very troublesome? That's not the problem. What constitutes a serious technical problem i

Images